Withdrawal Story of Weight Loss Medicine (A scenario to understand the benefit risk balance of a medicine)

A medicine with negative benefit to risk ratio has withdrawn from the US market. (Belviq) lorcaserin is a weight loss medication developed by Arena Pharmaceuticals approved for treating obesity together with diet and exercise in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or

error: Content is protected !!